Last Updated : April 11, 2025
Details
FilesProject Status:
Active
Project Line:
Health Technology Review
Project Sub Line:
Technology Review
Project Number:
HC0106-000
The objective of this review is to identify new evidence available since the 2019 Canadian Drug Expert Committee review for cerliponase alfa (Brineura) for the treatment of pediatric patients with neuronal ceroid lipofuscinosis type 2 disease.
Call for feedback
Call for feedback :
Feedback Due By
Feedback Due By :
Consultation document
Consultation document :
Proposed Scope
Product Line
Product Line :
Health Technology Review
Project Number
Project Number :
HC0106-000
Files
Last Updated : April 11, 2025